Nonalcoholic fatty liver disease (NAFLD) defines a wide pathological spectrum ranging from
simple steatosis to nonalcoholic steatohepatitis (NASH) which may predispose to liver …

Genetics and epigenetics play a key role in the development of several diseases, including
nonalcoholic fatty liver disease (NAFLD). Family studies demonstrate that first degree …

Nonalcoholic steatohepatitis (NASH) is considered as a progressive form of nonalcoholic
fatty liver disease (NAFLD). To distinguish NASH from nonalcoholic fatty liver (NAFL), we …

Background & Aims microRNAs (miRNAs) are deregulated in non-alcoholic fatty liver
disease (NAFLD) and have been proposed as useful markers for the diagnosis and …

Nonalcoholic fatty liver disease (NAFLD) is a metabolic‐related disorder ranging from
steatosis to steatohepatitis, which may progress to cirrhosis and hepatocellular carcinoma …

Nonalcoholic fatty liver disease (NAFLD) is common worldwide. The importance of genetic
and epigenetic changes in etiology and pathogenesis of NAFLD has been increasingly …

Liver biopsy is currently the only reliable method to establish nonalcoholic fatty liver disease
(NAFLD) severity. However, this technique is invasive and occasionally associated with …

Background The spectrum of nonalcoholic fatty liver disease (NAFLD) describes disease
conditions deteriorating from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis …

This review intends to uncover how information from large-scale genetic profiling (whole
genome sequencing, and whole exome sequencing) of nonalcoholic fatty liver disease …

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in
industrialized countries, affecting about 25% of the general population. NAFLD is a benign …